Liberty Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-260
Closed -$8K 240
2021
Q3
$8K Buy
+260
New +$8.82K ﹤0.01% 857
2020
Q4
Sell
-12
Closed 939
2020
Q3
$0 Hold
12
﹤0.01% 854
2020
Q2
$0 Hold
12
﹤0.01% 854
2020
Q1
$0 Hold
12
﹤0.01% 885
2019
Q4
$0 Hold
12
﹤0.01% 904
2019
Q3
$0 Buy
+12
New +$458 ﹤0.01% 866
2019
Q1
Sell
-36
Closed -$1K 732
2018
Q4
$1K Buy
+36
New +$1.89K ﹤0.01% 695

Other funds holding AVNS

Liberty Wealth Management's AVNS Position: Q4 2021 in Review

Liberty Wealth Management sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 260 shares — an estimated $8K sold.

Liberty Wealth Management first reported a position in AVNS in Q4 2018 and held it in 7 quarters. The position peaked at $8K in Q3 2021. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

  • Liberty Wealth Management reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 260 Avanos Medical shares in Q4 2021, an estimated $8K.
  • Liberty Wealth Management first reported a position in Avanos Medical in Q4 2018 and held it in 7 quarters.
  • Liberty Wealth Management's Avanos Medical position peaked at $8K in Q3 2021.
  • 297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.